Botulinum Toxin Type A Treatment Report

Category: Prescription Drugs

true

Generic Name: Botulinum Toxin Type A

What is Botulinum Toxin Type A?

An example of Botulinum Toxin Type A

Botulinum Toxin Type A is a neuromuscular blocker age. It is used to treat various types of dystonia (neurological movement disorders); for blepharospasm and strabismus; for primary axillary hyperhidrosis (excessive perspiration); and it is also used for cosmetic purposes.

Reported Purpose & Perceived Effectiveness

Reasons and Perceived effectiveness
Perceived Effectiveness
Purpose # of patients # of patients with evaluations
Major
Moderate
Slight
None
Can’t tell
37 13 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none
20 7 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none
19 6 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none
14 6 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none
13 6 Efficacy_major Efficacy_none
9 4 Efficacy_major

See all 148 patients currently taking Botulinum Toxin Type A

Mouse over the table for more information

Reported Dosages

Frequently reported dosages based on patients currently taking Botulinum Toxin Type A. See all 59 dosages

  IU as needed 100units as needed as needed 1 app every 3 months 1 other every 3 months 100 units yearly 100 units every 3 months 200 units every 3 months 300 units every 3 months 100 units monthly
  4 Number of Patients: 4 16 Number of Patients: 16 4 Number of Patients: 4 4 Number of Patients: 4 4 Number of Patients: 4 5 Number of Patients: 5 27 Number of Patients: 27 16 Number of Patients: 16 4 Number of Patients: 4 4 Number of Patients: 4  

Reported Stop Reasons

Why Patients Stopped Taking Botulinum Toxin Type A (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 31   Did not seem to work: 40%
Course of treatment ended 21   Course of treatment ended: 27%
Other 15   Other: 19%
Side effects too severe 12   Side effects too severe: 15%
Not indicated 10   Not indicated: 13%
Expense 9   Expense: 12%
Doctor's advice 4   Doctor's advice: 5%
Personal research 4   Personal research: 5%

See all 76 patients who’ve stopped taking Botulinum Toxin Type A

Currently Taking Botulinum Toxin Type A

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Stopped Taking Botulinum Toxin Type A

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Botulinum Toxin Type A

Always
54 66%
Usually
8 10%
Sometimes
11 13%
Never
9 11%

Burden

Difficulty being on treatment

Burden of Botulinum Toxin Type A

Very
12 15%
Somewhat
10 12%
A little
23 28%
Not at all
37 45%

Cost

Paid out of pocket

Cost of Botulinum Toxin Type A

$200+
12 23%
$100-199
9 17%
$50-99
3 6%
$25-49
4 8%
< $25
25 47%

Sort by: Helpfulness | Most Recent

23 patient evaluations for Botulinum Toxin Type A

Purpose: Stiffness/Spasticity (Started Nov 15, 2010)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Apr 28, 2013   Led_efficacy_2Led_efficacy_2Led_defaultLed_defaultSlight SevereSevereSevereSevereSevere NeverNeverNeverNeverNever VeryVeryVeryVeryVery
Date
Apr 28, 2013
Advice & Tips
The first 2 times that I received the Botox injections my arm was not rigid after being on it for 3 weeks. It wore off in three months so I had to go back for another injection. The third time I noticed that my arm was a little weak so we decreased my dosage this helped. Then in November of 2012 I received more injections including my shoulder at that time my arm was like I had a stroke I could not use it at all.. So in April 2013 we decided not to continue the Botox. I still have stiffness but I am able to use my arm .
  • Icon_thumb_off 0 helpful marks
Purpose: Urinary Incontinence (Started Oct 17, 2012)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Jan 23, 2013   Led_efficacy_2Led_efficacy_2Led_defaultLed_defaultSlight NoneNoneNoneNoneNone SometimesSometimesSometimesSometimesSometimes A littleA littleA littleA littleA little
Date
Jan 23, 2013
Advice & Tips
I didn't work... I had the surgery to apply, but it didn't work like I was expecting...
  • Icon_thumb_off 0 helpful marks
Purpose: Sweating excessive (Started Nov 12, 2012)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Nov 12, 2012 100 units One time Led_efficacy_1Led_defaultLed_defaultLed_defaultNone MildMildMildMildMild SometimesSometimesSometimesSometimesSometimes VeryVeryVeryVeryVery
  • Icon_thumb_off 0 helpful marks
1 2 3 4 5 6 ... 8    You are at the first page First There is no previous page Prev | Next Go to the next page Last Go to the last page 

What is botulinum toxin type A?

Botulinum toxin type A is made from the bacteria that causes botulism. Botulinum toxin blocks nerve activity in the muscles, causing a temporary reduction in muscle activity.

Botulinum toxin type A is used to treat cervical dystonia (severe spasms in the neck muscles), or severe underarm sweating (hyperhidrosis).

Botulinum toxin type A is also used to treat certain eye muscle conditions caused by nerve disorders. This includes uncontrolled blinking or spasm of the eyelids, and a condition in which the eyes do not point in the same direction.

Botulinum toxin type A is also used to temporarily lessen the appearance of facial wrinkles.

Botulinum toxin type A may also be used for other purposes not listed in this medication guide.


Precautions

You should not receive this medication if you are allergic to botulinum toxin, or if you have an infection, swelling, or muscle weakness in the area where the medicine will be injected.

If you have any of these other conditions, you may need a dose adjustment or special tests to safely receive this medication.

  • amyotrophic lateral sclerosis (ALS, or "Lou Gehrig's disease");
  • myasthenia gravis;
  • Lambert-Eaton syndrome; or
  • heart disease.

Botulinum toxin type A is made using human plasma (part of the blood) and may contain viruses and other infectious agents that can cause disease. Although donated human plasma is screened, tested, and treated to reduce the risk of it containing anything that could cause disease, there is still a small possibility it could transmit disease. Talk with your doctor about the risks and benefits of using this medication.

FDA pregnancy category C. It is not known whether botulinum toxin is harmful to an unborn baby. Before you receive this medication, tell your doctor if you are pregnant or plan to become pregnant during treatment.

It is not known whether botulinum toxin passes into breast milk or if it could harm a nursing baby. Do not receive this medication without telling your doctor if you are breast-feeding a baby.

Avoid using underarm antiperspirants or deodorants for 24 hours after a botulinum toxin injection if you are being treated for excessive underarm sweating.

Avoid going back to your normal physical activities too quickly after receiving a botulinum toxin injection.

Back to top

Instructions

Seek emergency medical attention if you think you have received too much of this medicine.

Overdose symptoms may include muscle weakness, trouble swallowing, and weak or shallow breathing.

Since botulinum toxin has a temporary effect and is given at widely spaced intervals, missing a dose is not likely to be harmful.

Back to top

Side Effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

The botulinum toxin contained in this medication can spread to other body areas beyond where it was injected. This has caused serious life-threatening side effects in some people receiving botulism toxin injections, even for cosmetic purposes.

Call your doctor at once if you have any of these serious side effects, some of which can occur up to several weeks after an injection:

  • trouble breathing, talking, or swallowing;
  • drooping eyelids;
  • unusual or severe muscle weakness (especially in a body area that was not injected with the medication);
  • loss of bladder control;
  • problems with vision or depth perception;
  • crusting or drainage from your eyes;
  • severe skin rash or itching; or
  • chest pain or heavy feeling, pain spreading to the arm or shoulder, general ill feeling.

Less serious side effects may include:

  • muscle weakness near where the medicine was injected;
  • bruising, bleeding, pain, or tenderness where the injection was given;
  • headache, muscle stiffness, neck or back pain;
  • fever, cough, sore throat, runny nose, nausea, flu symptoms,
  • dizziness, drowsiness, anxiety;
  • dry mouth, dry eyes;
  • increased sweating in areas other than the underarms;
  • itchy or watery eyes, increased sensitivity to light; or
  • eyelid swelling or bruising.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Back to top

Interactions

Before you receive this medication, tell your doctor if you are also taking:

  • an antibiotic such as amikacin (Amikin), gentamicin (Garamycin), kanamycin (Kantrex), neomycin (Mycifradin, Neo-Fradin, Neo-Tab), netilmicin (Netromycin), paromomycin (Humatin, Paromycin), streptomycin, tobramycin (Nebcin, Tobi).

This list is not complete and there may be other drugs that can interact with botulinum toxin type A. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.

Other Names

Botox, Botox Cosmetic, and botulinum toxin type A

Back to top

Disclaimer

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2004 Cerner Multum, Inc. Version 2.05. Revision date 8/23/04

Last updated: